Tuberculosis Supranational Reference Laboratories : A Global Approach - 12/11/19
Résumé |
The World Health Organization Supranational TB Reference Laboratory Network (SRLN) has served as the backbone for TB drug-resistance surveillance and diagnosis since 1994 and remains a key WHO programme for antimicrobial resistance (AMR) surveillance at the global level. SRLN is a great technical resource for proficiency testing to ensure accuracy of drug-susceptibility testing, scale-up, capacity development in countries and provides unique support to the reliable detection of drug resistance. Technical assistance from individual SRLs has been supported by a variety of mechanisms but funding for the SRLN has become increasingly challenging.
Le texte complet de cet article est disponible en PDF.Keywords : Tuberculosis, WHO TB supranational reference laboratory, Drug susceptibility testing, Quality assurance
Plan
Vol 40 - N° 4
P. 755-762 - décembre 2019 Retour au numéro
Article précédent
- How Can the Tuberculosis Laboratory Aid in the Patient-Centered Diagnosis and Management of Tuberculosis?
- Akos Somoskovi, Max Salfinger
- Treatment of Drug-Susceptible Tuberculosis
- Beth Shoshana Zha, Payam Nahid
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?